Dermoscopic features of skin lesions in patients with mastocytosis

Archives of Dermatology

Volumn 147, Issue 8, 2011, Pages 932-940

  Vano Galvan, Sergio ^a   Álvarez Twose, Iván ^b,c   De Las Heras, Elena ^a   Morgado, J M ^b,c   Matito, Almudena ^b,c   Sánchez Muñoz, Laura ^b,c   Planas, Maria Nieves ^a   Jaén, Pedro ^a,b   Orfao, Alberto ^c,d   Escribano, Luis ^b,c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c Centro de Investigacion del Cancer   (Spain)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; TRYPTASE;

ADOLESCENT; ADULT; AGED; ANTIMEDIATOR THERAPY; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EPILUMINESCENCE MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; LABORATORY TEST; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MASTOCYTOSIS; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPAIN; TELANGIECTASIA; THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DERMOSCOPY; FEMALE; HUMANS; INFANT; MALE; MASTOCYTOSIS, CUTANEOUS; MIDDLE AGED; YOUNG ADULT;

EID: 80051700215     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.190     Document Type: Article

References (42)

1. Soter NA. The skin in mastocytosis. J Invest Dermatol. 1991;96(3)(suppl):32S-39S.
2. Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. Ann Allergy. 1994;73(3):197-207. (Pubitemid 24288437)
3. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol. 1995;32(4):545-564.
4. Alto WA, Clarcq L. Cutaneous and systemic manifestations of mastocytosis. Am Fam Physician. 1999;59(11):3047-3054, 3059-3060.
5. Katsamba AD, Karpouzis AJ, Koumantaki-Mathioudaki E, Jorizzo JL. Mastocytosis with skin manifestations: current status. J Eur Acad Dermatol Venereol. 1999;13(3):155-165.
6. Soter NA. Mastocytosis and the skin. Hematol Oncol Clin North Am. 2000;14(3):537-555, vi. (Pubitemid 30436933)
7. Horny HP, Metcalfe DD, Bennet JM, et al, Swerdlow SH, Campo E, Harris NL, et al eds. Mastocytosis. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research and Cancer; 2008:54-63.
8. Parkes Weber F, Rast H. Telangiectasia macularis eruptiva perstans: a telangiectatic and relatively pigmentless variety of urticaria pigmentosa of adults. Acta Derm Venereol (Stockh). 1935;16:216-224.
9. Allen BR. Telangiectasia macularis perstans. Br J Dermatol. 1978;99(suppl 16):28-29. (Pubitemid 9007030)
10. Sarkany RPE, Monk BE, Handfield-Jones SE. Telangiectasia macularis eruptiva perstans: a case report and review of the literature. Clin Exp Dermatol. 1998;23(1):38-39. (Pubitemid 28218198)
11. Hartmann K, Henz BM. Classification of cutaneous mastocytosis: a modified consensus proposal. Leuk Res. 2002;26(5):483-486. (Pubitemid 34251094)
12. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007;37(6):435-453. (Pubitemid 46817344)
13. Garriga MM, Friedman MM, Metcalfe DD. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol. 1988;82(3, pt 1):425-432.
14. Wolff K, Komar M, Petzelbauer P. Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res. 2001;25(7):519-528. (Pubitemid 32506758)
15. Longley BJ Jr, Metcalfe DD, Tharp M, et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999;96(4):1609-1614. (Pubitemid 29098499)
16. Bodemer C, Hermine O, Palmérini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol. 2010;130(3):804-815.
17. Argenziano G, Mordente I, Ferrara G, Sgambato A, Annese P, Zalaudek I. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol. 2008;159(2):331-336. (Pubitemid 352009843)
18. Akay BN, Kittler H, Sanli H, Harmankaya K, Anadolu R. Dermatoscopic findings of cutaneous mastocytosis. Dermatology. 2009;218(3):226-230.
19. Arpaia N, Cassano N, Vena GA. Lessons on dermoscopy: pigment network in nonmelanocytic lesions. Dermatol Surg. 2004;30(6):929-930. (Pubitemid 38765734)
20. Saida T, Koga H. Dermoscopic patterns of acral melanocytic nevi: their variations, changes, and significance. Arch Dermatol. 2007;143(11):1423-1426. (Pubitemid 350146270)
21. Yadav S, Vossaert KA, Kopf AW, Silverman M, Grin-Jorgensen C. Histopathologic correlates of structures seen on dermoscopy (epiluminescence microscopy). Am J Dermatopathol. 1993;15(4):297-305. (Pubitemid 23235260)
22. Zaballos P, Puig S, Llambrich A, Malvehy J. Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol. 2008;144(1):75-83. (Pubitemid 351159392)
23. Haas N, Hermes B, Henz BM. Detection of a novel pigment network feature in reticulated black solar lentigo by high-resolution epiluminescence microscopy. Am J Dermatopathol. 2002;24(3):213-217. (Pubitemid 34587250)
24. De Giorgi V, Massi D, Stante M, Carli P. False "melanocytic" parameters shown by pigmented seborrheic keratoses: a finding which is not uncommon in dermoscopy. Dermatol Surg. 2002;28(8):776-779. (Pubitemid 34913296)
25. Oztas MO, Gurer MA. Dermoscopic features of accessory nipples. Int J Dermatol. 2007;46(10):1067-1068. (Pubitemid 47506376)
26. Scope A, Marghoob AA, Chen CS, Lieb JA, Weinstock MA, Halpern AC; SONIC Study Group. Dermoscopic patterns and subclinical melanocytic nests in normalappearing skin. Br J Dermatol. 2009;160(6):1318-1321.
27. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest. 1995;72(2):215-222.
28. Bugatti L, Filosa G, Broganelli P, Tomasini C. Psoriasis-like dermoscopic pattern of clear cell acanthoma. J Eur Acad Dermatol Venereol. 2003;17(4):452-455. (Pubitemid 36869313)
29. Altamura D, Piccolo D, Lozzi GP, Peris K. Eccrine poroma in an unusual site: a clinical and dermoscopic simulator of amelanotic melanoma. JAmAcad Dermatol. 2005;53(3):539-541. (Pubitemid 41196002)
30. Avilés-Izquierdo JA, Velázquez-Tarjuelo D, Lecona-Echevarría M, Lázaro-Ochaita P. Dermoscopic features of eccrine poroma [in Spanish]. Actas Dermosifiliogr. 2009;100(2):133-136.
31. Nicolino R, Zalaudek I, Ferrara G, et al. Dermoscopy of eccrine poroma. Dermatology. 2007;215(2):160-163. (Pubitemid 47230727)
32. Bugatti L, Filosa G, De Angelis R. The specific dermoscopical criteria of Bowen's disease. J Eur Acad Dermatol Venereol. 2007;21(5):700-701. (Pubitemid 46916782)
33. Blum A, Metzler G, Bauer J. Polymorphous vascular patterns in dermoscopy as a sign of malignant skin tumors: a case of an amelanotic melanoma and a porocarcinoma. Dermatology. 2005;210(1):58-59. (Pubitemid 39656722)
34. Palmer A, Bowling J. Dermoscopic appearance of juvenile xanthogranuloma. Dermatology. 2007;215(3):256-259. (Pubitemid 47378996)
35. Bryden AM, Dawe RS, Fleming C. Dermatoscopic features of benign sebaceous proliferation. Clin Exp Dermatol. 2004;29(6):676-677. (Pubitemid 39573665)
36. Zaballos P, Ara M, Puig S, Malvehy J. Dermoscopy of sebaceous hyperplasia. Arch Dermatol. 2005;141(6):808. (Pubitemid 41001100)
37. Cavicchini S, Tourlaki A, Tanzi C, Alessi E. Dermoscopy of solitary yellow lesions in adults. Arch Dermatol. 2008;144(10):1412.
38. Schwartz LB, Irani AM. Serum tryptase and the laboratory diagnosis of systemic mastocytosis. Hematol Oncol Clin North Am. 2000;14(3):641-657. (Pubitemid 30436938)
39. Sperr WR, Jordan J-H, Fiegl M, et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol. 2002;128(2):136-141. (Pubitemid 34639022)
40. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987;316(26):1622-1626. (Pubitemid 17082588)
41. Ludolph-Hauser D, Rue¨ff F, Fries C, Schöpf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet. 2001;357(9253):361-362. (Pubitemid 32128546)
42. Haeberli G, Brönnimann M, Hunziker T, Müller U. Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003;33(9):1216-1220. (Pubitemid 37108524)